SG184563A1 - Methods for measuring enzyme activity useful in determining cell viability in non-purified samples - Google Patents

Methods for measuring enzyme activity useful in determining cell viability in non-purified samples Download PDF

Info

Publication number: SG184563A1
Authority: SG; Singapore
Prior art keywords: sample; microorganism; polymerase; nucleic acid; enzyme
Prior art date: 2010-04-16

Application number

SG2012076097A

Other languages

English (en)

Inventor

Shawn Mark O'hara

Daniel R Zweitzig

Original Assignee

Zeus Scientific Inc

Shawn Mark O'hara

Daniel R Zweitzig

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-04-16

Filing date

2011-04-15

Publication date

2012-11-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44799329&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG184563(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2011-04-15 Application filed by Zeus Scientific Inc, Shawn Mark O'hara, Daniel R Zweitzig filed Critical Zeus Scientific Inc

2012-11-29 Publication of SG184563A1 publication Critical patent/SG184563A1/en

Links

238000000034 method Methods 0.000 title claims abstract description 114
230000000694 effects Effects 0.000 title claims abstract description 58
102000004190 Enzymes Human genes 0.000 title claims abstract description 54
108090000790 Enzymes Proteins 0.000 title claims abstract description 54
239000012521 purified sample Substances 0.000 title description 6
230000003833 cell viability Effects 0.000 title description 4
244000005700 microbiome Species 0.000 claims abstract description 68
238000001514 detection method Methods 0.000 claims abstract description 29
108010014303 DNA-directed DNA polymerase Proteins 0.000 claims abstract description 27
102000016928 DNA-directed DNA polymerase Human genes 0.000 claims abstract description 27
239000003153 chemical reaction reagent Substances 0.000 claims abstract description 9
238000003149 assay kit Methods 0.000 claims abstract description 5
210000001124 body fluid Anatomy 0.000 claims abstract description 5
239000010839 body fluid Substances 0.000 claims abstract description 5
150000007523 nucleic acids Chemical class 0.000 claims description 71
108020004707 nucleic acids Proteins 0.000 claims description 70
102000039446 nucleic acids Human genes 0.000 claims description 70
239000000758 substrate Substances 0.000 claims description 58
102000003960 Ligases Human genes 0.000 claims description 50
108090000364 Ligases Proteins 0.000 claims description 50
239000000203 mixture Substances 0.000 claims description 19
230000001419 dependent effect Effects 0.000 claims description 14
238000003556 assay Methods 0.000 claims description 12
230000009471 action Effects 0.000 claims description 10
230000002452 interceptive effect Effects 0.000 claims description 10
230000035899 viability Effects 0.000 claims description 8
239000013592 cell lysate Substances 0.000 claims description 7
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims description 6
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims description 6
238000012300 Sequence Analysis Methods 0.000 claims description 5
230000036961 partial effect Effects 0.000 claims description 5
108090000623 proteins and genes Proteins 0.000 claims description 5
108090000626 DNA-directed RNA polymerases Proteins 0.000 claims description 4
102000004163 DNA-directed RNA polymerases Human genes 0.000 claims description 4
238000002360 preparation method Methods 0.000 claims description 4
230000000845 anti-microbial effect Effects 0.000 claims description 3
239000004599 antimicrobial Substances 0.000 claims description 3
238000011534 incubation Methods 0.000 claims description 3
238000005464 sample preparation method Methods 0.000 claims description 3
238000012216 screening Methods 0.000 claims description 3
239000003795 chemical substances by application Substances 0.000 claims description 2
102000004169 proteins and genes Human genes 0.000 claims description 2
230000006037 cell lysis Effects 0.000 claims 2
238000003752 polymerase chain reaction Methods 0.000 abstract description 36
230000003321 amplification Effects 0.000 abstract description 13
238000003199 nucleic acid amplification method Methods 0.000 abstract description 13
238000003753 real-time PCR Methods 0.000 abstract description 12
230000000813 microbial effect Effects 0.000 abstract description 11
239000006166 lysate Substances 0.000 abstract description 10
239000008280 blood Substances 0.000 abstract description 8
210000004369 blood Anatomy 0.000 abstract description 8
230000014670 detection of bacterium Effects 0.000 abstract description 2
244000000010 microbial pathogen Species 0.000 abstract 1
239000000523 sample Substances 0.000 description 69
239000013615 primer Substances 0.000 description 41
108020004414 DNA Proteins 0.000 description 34
210000004027 cell Anatomy 0.000 description 26
241000894006 Bacteria Species 0.000 description 23
ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 18
ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 18
238000006243 chemical reaction Methods 0.000 description 18
230000001580 bacterial effect Effects 0.000 description 12
230000000295 complement effect Effects 0.000 description 9
239000000047 product Substances 0.000 description 9
BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 8
125000003729 nucleotide group Chemical group 0.000 description 8
108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 7
XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 7
102000012410 DNA Ligases Human genes 0.000 description 7
108010061982 DNA Ligases Proteins 0.000 description 7
229910019142 PO4 Inorganic materials 0.000 description 7
238000004458 analytical method Methods 0.000 description 7
238000009640 blood culture Methods 0.000 description 7
235000013305 food Nutrition 0.000 description 7
238000009396 hybridization Methods 0.000 description 7
238000012360 testing method Methods 0.000 description 7
102000053602 DNA Human genes 0.000 description 6
238000013459 approach Methods 0.000 description 6
239000002773 nucleotide Substances 0.000 description 6
230000002441 reversible effect Effects 0.000 description 6
241000588724 Escherichia coli Species 0.000 description 5
238000011109 contamination Methods 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
230000006872 improvement Effects 0.000 description 5
238000012986 modification Methods 0.000 description 5
230000004048 modification Effects 0.000 description 5
102000002281 Adenylate kinase Human genes 0.000 description 4
108020000543 Adenylate kinase Proteins 0.000 description 4
108091034117 Oligonucleotide Proteins 0.000 description 4
230000008901 benefit Effects 0.000 description 4
238000011161 development Methods 0.000 description 4
239000000975 dye Substances 0.000 description 4
230000002349 favourable effect Effects 0.000 description 4
230000012010 growth Effects 0.000 description 4
239000000463 material Substances 0.000 description 4
235000021317 phosphate Nutrition 0.000 description 4
230000008569 process Effects 0.000 description 4
238000003757 reverse transcription PCR Methods 0.000 description 4
241000186216 Corynebacterium Species 0.000 description 3
102100031780 Endonuclease Human genes 0.000 description 3
108060002716 Exonuclease Proteins 0.000 description 3
241000233866 Fungi Species 0.000 description 3
241000589902 Leptospira Species 0.000 description 3
108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 3
102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 3
206010040047 Sepsis Diseases 0.000 description 3
230000029918 bioluminescence Effects 0.000 description 3
238000005415 bioluminescence Methods 0.000 description 3
239000000872 buffer Substances 0.000 description 3
230000003247 decreasing effect Effects 0.000 description 3
239000000645 desinfectant Substances 0.000 description 3
102000013165 exonuclease Human genes 0.000 description 3
238000002866 fluorescence resonance energy transfer Methods 0.000 description 3
238000011901 isothermal amplification Methods 0.000 description 3
239000011777 magnesium Substances 0.000 description 3
238000005259 measurement Methods 0.000 description 3
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
239000010452 phosphate Substances 0.000 description 3
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 3
208000013223 septicemia Diseases 0.000 description 3
239000000126 substance Substances 0.000 description 3
210000001519 tissue Anatomy 0.000 description 3
241000588807 Bordetella Species 0.000 description 2
241000589968 Borrelia Species 0.000 description 2
241000193449 Clostridium tetani Species 0.000 description 2
108010042407 Endonucleases Proteins 0.000 description 2
241000588914 Enterobacter Species 0.000 description 2
241000606768 Haemophilus influenzae Species 0.000 description 2
208000016604 Lyme disease Diseases 0.000 description 2
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 2
108020004711 Nucleic Acid Probes Proteins 0.000 description 2
108091028043 Nucleic acid sequence Proteins 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
102000035195 Peptidases Human genes 0.000 description 2
206010036790 Productive cough Diseases 0.000 description 2
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
241000607768 Shigella Species 0.000 description 2
241000193998 Streptococcus pneumoniae Species 0.000 description 2
241000589886 Treponema Species 0.000 description 2
241000700605 Viruses Species 0.000 description 2
238000000137 annealing Methods 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
229940088710 antibiotic agent Drugs 0.000 description 2
238000009635 antibiotic susceptibility testing Methods 0.000 description 2
235000013361 beverage Nutrition 0.000 description 2
235000013351 cheese Nutrition 0.000 description 2
239000002299 complementary DNA Substances 0.000 description 2
238000004590 computer program Methods 0.000 description 2
-1 conditioners Substances 0.000 description 2
239000002537 cosmetic Substances 0.000 description 2
238000004925 denaturation Methods 0.000 description 2
230000036425 denaturation Effects 0.000 description 2
238000013461 design Methods 0.000 description 2
230000008030 elimination Effects 0.000 description 2
238000003379 elimination reaction Methods 0.000 description 2
230000007613 environmental effect Effects 0.000 description 2
239000007850 fluorescent dye Substances 0.000 description 2
235000011389 fruit/vegetable juice Nutrition 0.000 description 2
230000002538 fungal effect Effects 0.000 description 2
239000000499 gel Substances 0.000 description 2
230000036541 health Effects 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
238000009830 intercalation Methods 0.000 description 2
230000003834 intracellular effect Effects 0.000 description 2
238000002955 isolation Methods 0.000 description 2
229910052749 magnesium Inorganic materials 0.000 description 2
229910001425 magnesium ion Inorganic materials 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
235000013336 milk Nutrition 0.000 description 2
239000008267 milk Substances 0.000 description 2
210000004080 milk Anatomy 0.000 description 2
238000012544 monitoring process Methods 0.000 description 2
239000002853 nucleic acid probe Substances 0.000 description 2
244000052769 pathogen Species 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
210000003705 ribosome Anatomy 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
238000004904 shortening Methods 0.000 description 2
239000002689 soil Substances 0.000 description 2
210000003802 sputum Anatomy 0.000 description 2
208000024794 sputum Diseases 0.000 description 2
238000010186 staining Methods 0.000 description 2
229940031000 streptococcus pneumoniae Drugs 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
239000002351 wastewater Substances 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 description 1
XMGJGSKRRWXOIF-UHFFFAOYSA-N 2-(azepan-1-yl)ethyl 2-cyclohexyl-2-thiophen-3-ylacetate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C1CCCCC1C(C1=CSC=C1)C(=O)OCCN1CCCCCC1 XMGJGSKRRWXOIF-UHFFFAOYSA-N 0.000 description 1
FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
241000589291 Acinetobacter Species 0.000 description 1
241000186046 Actinomyces Species 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
108091023037 Aptamer Proteins 0.000 description 1
241001112741 Bacillaceae Species 0.000 description 1
241000193830 Bacillus <bacterium> Species 0.000 description 1
241000193738 Bacillus anthracis Species 0.000 description 1
208000031729 Bacteremia Diseases 0.000 description 1
241000606125 Bacteroides Species 0.000 description 1
241000606124 Bacteroides fragilis Species 0.000 description 1
235000018185 Betula X alpestris Nutrition 0.000 description 1
235000018212 Betula X uliginosa Nutrition 0.000 description 1
206010005098 Blastomycosis Diseases 0.000 description 1
241000588832 Bordetella pertussis Species 0.000 description 1
241000589969 Borreliella burgdorferi Species 0.000 description 1
241000589562 Brucella Species 0.000 description 1
241000589876 Campylobacter Species 0.000 description 1
241000606161 Chlamydia Species 0.000 description 1
241000193468 Clostridium perfringens Species 0.000 description 1
241000223203 Coccidioides Species 0.000 description 1
241000186227 Corynebacterium diphtheriae Species 0.000 description 1
IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
230000004544 DNA amplification Effects 0.000 description 1
239000003155 DNA primer Substances 0.000 description 1
CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
102000004533 Endonucleases Human genes 0.000 description 1
241000588921 Enterobacteriaceae Species 0.000 description 1
241000186811 Erysipelothrix Species 0.000 description 1
108090000371 Esterases Proteins 0.000 description 1
BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
206010017523 Fungaemia Diseases 0.000 description 1
201000000628 Gas Gangrene Diseases 0.000 description 1
241000606790 Haemophilus Species 0.000 description 1
241000589989 Helicobacter Species 0.000 description 1
241000588748 Klebsiella Species 0.000 description 1
241000589248 Legionella Species 0.000 description 1
241000589242 Legionella pneumophila Species 0.000 description 1
208000007764 Legionnaires' Disease Diseases 0.000 description 1
241000186781 Listeria Species 0.000 description 1
241000186779 Listeria monocytogenes Species 0.000 description 1
108060001084 Luciferase Proteins 0.000 description 1
239000005089 Luciferase Substances 0.000 description 1
DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
241001293418 Mannheimia haemolytica Species 0.000 description 1
108060004795 Methyltransferase Proteins 0.000 description 1
239000004909 Moisturizer Substances 0.000 description 1
241000186359 Mycobacterium Species 0.000 description 1
241000186366 Mycobacterium bovis Species 0.000 description 1
241000186362 Mycobacterium leprae Species 0.000 description 1
241000187479 Mycobacterium tuberculosis Species 0.000 description 1
241000204031 Mycoplasma Species 0.000 description 1
241000588652 Neisseria gonorrhoeae Species 0.000 description 1
241000588650 Neisseria meningitidis Species 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
238000010222 PCR analysis Methods 0.000 description 1
238000002944 PCR assay Methods 0.000 description 1
241000606856 Pasteurella multocida Species 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
239000004365 Protease Substances 0.000 description 1
241000588769 Proteus <enterobacteria> Species 0.000 description 1
241000589516 Pseudomonas Species 0.000 description 1
241000589517 Pseudomonas aeruginosa Species 0.000 description 1
241000606683 Rickettsiaceae Species 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
241000607142 Salmonella Species 0.000 description 1
241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
241000577483 Salmonella enterica subsp. enterica serovar Paratyphi B Species 0.000 description 1
241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
241000607720 Serratia Species 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
241000589970 Spirochaetales Species 0.000 description 1
241000191967 Staphylococcus aureus Species 0.000 description 1
241000194017 Streptococcus Species 0.000 description 1
108010006785 Taq Polymerase Proteins 0.000 description 1
241000202898 Ureaplasma Species 0.000 description 1
241000607598 Vibrio Species 0.000 description 1
241000607626 Vibrio cholerae Species 0.000 description 1
241000607734 Yersinia <bacteria> Species 0.000 description 1
241000607479 Yersinia pestis Species 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
HDRRAMINWIWTNU-NTSWFWBYSA-N [[(2s,5r)-5-(2-amino-6-oxo-3h-purin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@H]1CC[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HDRRAMINWIWTNU-NTSWFWBYSA-N 0.000 description 1
ARLKCWCREKRROD-POYBYMJQSA-N [[(2s,5r)-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)CC1 ARLKCWCREKRROD-POYBYMJQSA-N 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
239000008272 agar Substances 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
238000002820 assay format Methods 0.000 description 1
235000015173 baked goods and baking mixes Nutrition 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
239000011324 bead Substances 0.000 description 1
235000013405 beer Nutrition 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
238000003390 bioluminescence detection Methods 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
239000010836 blood and blood product Substances 0.000 description 1
229940125691 blood product Drugs 0.000 description 1
235000014121 butter Nutrition 0.000 description 1
235000015155 buttermilk Nutrition 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
238000002512 chemotherapy Methods 0.000 description 1
238000011278 co-treatment Methods 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
235000009508 confectionery Nutrition 0.000 description 1
238000010276 construction Methods 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
239000013068 control sample Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000006071 cream Substances 0.000 description 1
238000012258 culturing Methods 0.000 description 1
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
MXHRCPNRJAMMIM-UHFFFAOYSA-N desoxyuridine Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-UHFFFAOYSA-N 0.000 description 1
230000014155 detection of activity Effects 0.000 description 1
230000001627 detrimental effect Effects 0.000 description 1
238000010586 diagram Methods 0.000 description 1
239000005546 dideoxynucleotide Substances 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
230000029087 digestion Effects 0.000 description 1
235000020188 drinking water Nutrition 0.000 description 1
239000003651 drinking water Substances 0.000 description 1
239000003814 drug Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
230000000688 enterotoxigenic effect Effects 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
230000009088 enzymatic function Effects 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
229960005542 ethidium bromide Drugs 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
239000007943 implant Substances 0.000 description 1
238000000099 in vitro assay Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
229940115932 legionella pneumophila Drugs 0.000 description 1
235000015122 lemonade Nutrition 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
235000013622 meat product Nutrition 0.000 description 1
239000012528 membrane Substances 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
108091070501 miRNA Proteins 0.000 description 1
239000002679 microRNA Substances 0.000 description 1
238000010208 microarray analysis Methods 0.000 description 1
238000013048 microbiological method Methods 0.000 description 1
238000002156 mixing Methods 0.000 description 1
230000001333 moisturizer Effects 0.000 description 1
238000003032 molecular docking Methods 0.000 description 1
230000036457 multidrug resistance Effects 0.000 description 1
230000036963 noncompetitive effect Effects 0.000 description 1
239000002674 ointment Substances 0.000 description 1
239000002751 oligonucleotide probe Substances 0.000 description 1
238000005457 optimization Methods 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
244000045947 parasite Species 0.000 description 1
230000003071 parasitic effect Effects 0.000 description 1
238000009928 pasteurization Methods 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
230000002688 persistence Effects 0.000 description 1
UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
235000019833 protease Nutrition 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000008439 repair process Effects 0.000 description 1
210000002345 respiratory system Anatomy 0.000 description 1
108020004418 ribosomal RNA Proteins 0.000 description 1
238000005070 sampling Methods 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
239000002453 shampoo Substances 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
231100000027 toxicology Toxicity 0.000 description 1
238000012546 transfer Methods 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
229940118696 vibrio cholerae Drugs 0.000 description 1
238000012800 visualization Methods 0.000 description 1
235000013618 yogurt Nutrition 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Engineering & Computer Science (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

SG2012076097A 2010-04-16 2011-04-15 Methods for measuring enzyme activity useful in determining cell viability in non-purified samples SG184563A1 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US32494910P	2010-04-16	2010-04-16
US32493910P	2010-04-16	2010-04-16
US32541310P	2010-04-19	2010-04-19
PCT/US2011/032600 WO2011130584A2 (fr)	2010-04-16	2011-04-15	Procédés de mesure de l'activité enzymatique utiles pour la détermination de la viabilité cellulaire dans des échantillons non purifiés

Publications (1)

Publication Number	Publication Date
SG184563A1 true SG184563A1 (en)	2012-11-29

Family

ID=44799329

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SG2012076097A SG184563A1 (en)	2010-04-16	2011-04-15	Methods for measuring enzyme activity useful in determining cell viability in non-purified samples
SG10201502900PA SG10201502900PA (en)	2010-04-16	2011-04-15	Methods for measuring enzyme activity useful in determining cell viability in non-purified samples

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SG10201502900PA SG10201502900PA (en)	2010-04-16	2011-04-15	Methods for measuring enzyme activity useful in determining cell viability in non-purified samples

Country Status (16)

Country	Link
US (3)	US20130196318A1 (fr)
EP (3)	EP3284831B1 (fr)
JP (2)	JP2013537399A (fr)
KR (2)	KR20130094714A (fr)
CN (1)	CN103328652B (fr)
AP (1)	AP2012006530A0 (fr)
AU (2)	AU2011239587B2 (fr)
CA (1)	CA2796676C (fr)
EA (1)	EA201291001A1 (fr)
ES (3)	ES2739806T3 (fr)
MY (1)	MY161567A (fr)
NZ (2)	NZ701866A (fr)
PH (2)	PH12012502065A1 (fr)
SG (2)	SG184563A1 (fr)
WO (1)	WO2011130584A2 (fr)
ZA (1)	ZA201208522B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ701866A (en)	2010-04-16	2016-07-29	Zeus Scientific Inc	Methods for measuring enzyme activity useful in determining cell viability in non-purified samples
KR20150005511A (ko) *	2012-01-05	2015-01-14	제우스 사이언티픽, 아이엔씨.	개선된 dna 중합효소 활성 분석 및 생육성 미생물의 검출을 가능하게 하는 방법
CN104520438A (zh) *	2012-04-12	2015-04-15	宙斯科技公司	用于任何聚合酶延伸活性的灵敏的,定量的聚合酶活性检测和用于确定活细胞的存在的方法
GB201412316D0 (en) *	2014-07-10	2014-08-27	Momentum Bioscience Ltd	Detecting the absence of micro-organisms
GB2528647A (en) *	2014-07-10	2016-02-03	Momentum Bioscience Ltd	Detecting viable microorganisms
US9879328B2 (en) *	2014-11-21	2018-01-30	GeneWeave Biosciences, Inc.	Mechanisms of antimicrobial susceptibility
US10662484B1 (en)	2016-03-24	2020-05-26	Bench in a Box, LLC	Two universal duplex primer sets and a combined real-time PCR and high resolution melt analysis assay for the amplification of gram-positive and gram-negative bacteria
GB201805479D0 (en)	2018-04-03	2018-05-16	Momentum Bioscience Ltd	Microorganism separation and detection
GB201914538D0 (en)	2019-10-08	2019-11-20	Momentum Bioscience Ltd	Microorganism capture from antimicrobial-containing solution
US20230112608A1 (en)	2021-10-13	2023-04-13	Disruptive Oil And Gas Technologies Corp	Nanobubble dispersions generated in electrochemically activated solutions
CN114032285B (zh) *	2021-11-24	2022-05-24	北京擎科生物科技有限公司	PolyA聚合酶活性检测方法
US20250191691A1 (en) *	2023-12-07	2025-06-12	California Institute Of Technology	Methods for the translated alignment of transcriptomic data at single-cell resolution
GB202405229D0 (en)	2024-04-12	2024-05-29	Momentum Bioscience Ltd	Microorganism enumeration

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS501953B1 (fr)	1968-08-05	1975-01-22
JPS505942B1 (fr)	1970-08-23	1975-03-08
JPS6054697A (ja) *	1983-09-05	1985-03-29	イザド−ラ　ブロドスキイ	診断方法および装置
US4683195A (en)	1986-01-30	1987-07-28	Cetus Corporation	Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en)	1985-03-28	1987-07-28	Cetus Corporation	Process for amplifying nucleic acid sequences
SE462497B (sv) †	1988-11-30	1990-07-02	Clas Fredrik Runesson Kaelland	Saett foer att aktivitetsbestaemma polymeraser
ATE143696T1 (de) *	1989-02-28	1996-10-15	Canon Kk	Partiell doppelsträngiges oligonukleotid und verfahren zu seiner bildung
US5143854A (en)	1989-06-07	1992-09-01	Affymax Technologies N.V.	Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
DE4027616A1 (de) *	1990-08-31	1992-03-05	Boehringer Mannheim Gmbh	Verfahren zur bestimmung von polymerase-aktivitaet
WO1993023560A1 (fr)	1992-05-11	1993-11-25	Schuepbach Joerg	Procede de mise en evidence de la transcriptase reverse
US5489508A (en) †	1992-05-13	1996-02-06	University Of Texas System Board Of Regents	Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
US5629154A (en) †	1993-11-12	1997-05-13	Geron Corporation	Telomerase activity assays
JPH0622798A (ja) *	1992-07-07	1994-02-01	Hitachi Ltd	塩基配列決定法
US5719028A (en) *	1992-12-07	1998-02-17	Third Wave Technologies Inc.	Cleavase fragment length polymorphism
US5863726A (en) †	1993-11-12	1999-01-26	Geron Corporation	Telomerase activity assays
GB2303919B (en)	1994-07-13	1998-08-26	Secr Defence	Assay of a microorganism by quantification of adenylate kinase involving magnesium ion and adenosine diphosphate
US6054278A (en) *	1997-05-05	2000-04-25	The Perkin-Elmer Corporation	Ribosomal RNA gene polymorphism based microorganism identification
PT1205559E (pt) *	1999-07-28	2009-08-04	Kaken Pharma Co Ltd	Método para detectar microrganismos patogénicos e agentes antimicrobianos, método para avaliar o efeito medicamentoso de agentes antimicrobianos e agentes antimicrobianos
GB9923846D0 (en)	1999-10-09	1999-12-08	Quip Technology Limited	Reverse transcriptase assay
AU2003260815A1 (en) *	2002-08-08	2004-02-25	University Of Lausanne	Method for the rapid assessment of the presence and viability of bacterial cells and use thereof________________________
US20050136439A1 (en) *	2003-09-12	2005-06-23	North Carolina State University	Novel methods of inorganic compound discovery and synthesis
GB0508981D0 (en) *	2005-05-03	2005-06-08	Acolyte Biomedica Ltd	Distinguishing cells in a sample
US8080375B2 (en) *	2005-05-18	2011-12-20	Iseao Technologies Limited	Methods and kits for detecting an enzyme capable of modifying a nucleic acid
WO2007076420A2 (fr) *	2005-12-20	2007-07-05	Ming-Sheng Lee	Appareil, procedes et produits pour la detection de mutation genetique
US7947447B2 (en) *	2007-01-16	2011-05-24	Somalogic, Inc.	Method for generating aptamers with improved off-rates
CA2692800A1 (fr)	2007-07-09	2009-01-15	Christopher John Stanley	Detection de microorganismes en fonction de leur activite de lignase adn a dependance nad
NZ701866A (en)	2010-04-16	2016-07-29	Zeus Scientific Inc	Methods for measuring enzyme activity useful in determining cell viability in non-purified samples

2011
- 2011-04-15 NZ NZ701866A patent/NZ701866A/en not_active IP Right Cessation
- 2011-04-15 KR KR1020127030167A patent/KR20130094714A/ko not_active Ceased
- 2011-04-15 AU AU2011239587A patent/AU2011239587B2/en not_active Ceased
- 2011-04-15 EP EP17194583.5A patent/EP3284831B1/fr active Active
- 2011-04-15 JP JP2013505162A patent/JP2013537399A/ja active Pending
- 2011-04-15 AP AP2012006530A patent/AP2012006530A0/xx unknown
- 2011-04-15 PH PH1/2012/502065A patent/PH12012502065A1/en unknown
- 2011-04-15 SG SG2012076097A patent/SG184563A1/en unknown
- 2011-04-15 SG SG10201502900PA patent/SG10201502900PA/en unknown
- 2011-04-15 US US13/641,480 patent/US20130196318A1/en not_active Abandoned
- 2011-04-15 CN CN201180019406.9A patent/CN103328652B/zh active Active
- 2011-04-15 ES ES17194583T patent/ES2739806T3/es active Active
- 2011-04-15 NZ NZ720529A patent/NZ720529A/en not_active IP Right Cessation
- 2011-04-15 EP EP11769633.6A patent/EP2558600B2/fr active Active
- 2011-04-15 WO PCT/US2011/032600 patent/WO2011130584A2/fr not_active Ceased
- 2011-04-15 MY MYPI2012004567A patent/MY161567A/en unknown
- 2011-04-15 ES ES19187658T patent/ES2906061T3/es active Active
- 2011-04-15 KR KR1020187021294A patent/KR102068136B1/ko active Active
- 2011-04-15 CA CA2796676A patent/CA2796676C/fr active Active
- 2011-04-15 EA EA201291001A patent/EA201291001A1/ru unknown
- 2011-04-15 EP EP19187658.0A patent/EP3617320B1/fr active Active
- 2011-04-15 ES ES11769633T patent/ES2644258T5/es active Active
2012
- 2012-11-13 ZA ZA2012/08522A patent/ZA201208522B/en unknown
2015
- 2015-06-12 US US14/737,736 patent/US10870894B2/en active Active
- 2015-08-12 US US14/825,092 patent/US10876173B2/en active Active
2016
- 2016-02-12 PH PH12016500300A patent/PH12016500300A1/en unknown
- 2016-06-09 AU AU2016203878A patent/AU2016203878A1/en not_active Abandoned
2017
- 2017-04-25 JP JP2017086485A patent/JP6603956B2/ja active Active

Also Published As

Publication number	Publication date
ES2739806T3 (es)	2020-02-04
CA2796676C (fr)	2020-07-14
KR20180086526A (ko)	2018-07-31
EP2558600A2 (fr)	2013-02-20
PH12016500300A1 (en)	2019-02-04
EP2558600A4 (fr)	2014-04-30
AP3635A (fr)	2016-03-09
WO2011130584A3 (fr)	2013-07-11
ES2644258T3 (es)	2017-11-28
ES2644258T5 (es)	2021-02-02
SG10201502900PA (en)	2015-06-29
ZA201208522B (en)	2014-08-27
US10870894B2 (en)	2020-12-22
CA2796676A1 (fr)	2011-10-20
JP6603956B2 (ja)	2019-11-13
EP3617320B1 (fr)	2022-01-26
ES2906061T3 (es)	2022-04-13
EP3617320A1 (fr)	2020-03-04
EP3284831A1 (fr)	2018-02-21
WO2011130584A2 (fr)	2011-10-20
KR102068136B1 (ko)	2020-01-20
JP2017148067A (ja)	2017-08-31
AU2011239587A1 (en)	2012-11-08
JP2013537399A (ja)	2013-10-03
CN103328652A (zh)	2013-09-25
AP2012006530A0 (en)	2012-10-31
US20180230551A1 (en)	2018-08-16
AU2011239587B2 (en)	2016-03-10
EP2558600B2 (fr)	2020-06-17
US20170321287A1 (en)	2017-11-09
US10876173B2 (en)	2020-12-29
KR20130094714A (ko)	2013-08-26
US20130196318A1 (en)	2013-08-01
EP2558600B1 (fr)	2017-10-04
EA201291001A1 (ru)	2013-09-30
NZ720529A (en)	2017-01-27
MY161567A (en)	2017-04-28
CN103328652B (zh)	2016-12-28
AU2016203878A1 (en)	2016-06-30
NZ701866A (en)	2016-07-29
EP3284831B1 (fr)	2019-07-24
PH12012502065A1 (en)	2019-07-10

Publication	Publication Date	Title
US10870894B2 (en)	2020-12-22	Methods for measuring enzyme activity useful in determining cell viability in non-purified samples
JP2013537399A5 (fr)	2016-03-10
EP2179052B1 (fr)	2012-11-14	Détection de micro-organismes, basée sur leur activité ligase nad-dépendante
AU2017201390A1 (en)	2017-03-23	Improved methods for determining cell viability using molecular nucleic acid-based techniques
US20150322478A1 (en)	2015-11-12	Detection of bacteria and fungi
JP2014502510A5 (fr)	2016-07-28
Class et al.	2010	Patent application title: Methods for Detection of Micro-Organisms Inventors: Christopher John Stanley (Cambridge, GB) Stuart Wilson (London, GB) Assignees: MICROSEN MEDTECH LIMITED